219
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Therapeutic effects of modafinil in ischemic stroke; possible role of NF-κB downregulation

ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 558-564 | Received 20 Jul 2019, Accepted 14 Sep 2019, Published online: 23 Sep 2019
 

Abstract

Background: The phenomenon of ischemic stroke receives maximal attention nowadays. Many studies are designed to discover new therapies for reducing debilitating consequences of this disorder. Development of stroke-related tissue damage is due to the combination of blood flow occlusion and reperfusion phase. Inflammatory pathways participate in excess oxidative stress formation after reperfusion. Modafinil is a well-known medication prescribed for sleep disorders. Recently, several studies have focused on finding new indications for modafinil treatment. Anti-inflammatory effects of modafinil through disrupting NF-κB signaling pathway is reported previously. Downregulation of inflammatory cytokines and further oxidative damage have also been mentioned in various experiments. So far, no specific experiment had been conducted to assess the anti-inflammatory effects of modafinil on ischemic stroke.

Material and methods: We evaluated outcomes of acutely administered modafinil on post-stroke behaviors and histopathological features (including apoptotic caspase-3 expressing neurons) through bilateral common carotid artery occlusion in rats. Alterations in concentrations of TNFɑ and IL-1β were assessed, together with malon di-aldehyde (MDA) to represent oxidation level. Western blotting was used to reveal the involvement of NF-κB downregulation. Considering possible alterations in blood flow and neuronal metabolism, we also assessed the effects of modafinil on cerebral glucose metabolism through PET scan.

Results and discussion: Modafinil exhibited promising effects on remission of behavioral deficits and the number of degenerated neurons in ischemic hippocampus CA1 region. IL-1β and MDA levels were downregulated in treated animals. However, no significant alteration was observed in PET results and TNFɑ between treated and non-treated ischemic brains. Decreased protein levels of NF-κB was also measured in modafinil treated animals.

Conclusion: Our findings demonstrate a promising therapeutic effect of modafinil for animal models of stroke.

Correction Statement

This article has been republished with minor change. This change do not impact the academic content of the article.

Ethical approval

All the experiments were in accordance with the guidelines of Tehran University of medical sciences and approved by the Animal Ethics Committee.

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability

All the necessary data is included in the article. Further data will be shared by request.

Additional information

Funding

This study was funded by Experimental Medicine Research Center, Tehran University of Medical Sciences and Health Services [97-02-30-384].
This study was funded by Experimental Medicine Research Center, Tehran University of Medical Sciences and Health Services [97-02-30-384].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,339.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.